|
|
 |
|
Viewing report
|
|
 |
 |
In Vitro Diagnostic Companies Analysis
Espicom Business Intelligence Ltd, Sep 2007, Pages: 166
This new report from provides an evaluation of the products, alliances and performance of over 30 leading global players.
Evaluation of the products, alliances and performance of over 30 leading global players.
HUGE POTENTIAL
The global market for in vitro diagnostics (IVD) in 2007 is estimated to be US$34 billion and we expect growth to be around 9% annually.
Although in vitro diagnostics influence more than 60% of clinical decisions, IVD sales represent only a small proportion of total healthcare expenditures; in 2005 IVD sales in Europe totalled less that 2% of total healthcare expenditure. However, clinicians are under increasing pressure for better clinical outcomes and to control cost through efficient disease management. The early detection and treatment of long-term conditions is critical, and modern, fast and effective diagnostics are essential to meeting these aims.
INNOVATION IS DRIVING CHANGE
For example, molecular diagnostics is the fastest growing segment of clinical diagnostics with a growth rate of around 10-15% and is estimated to be worth approximately US$2.4 billion.
By detecting DNA and RNA sequences characteristic of bacteria, viruses or cells, molecular diagnostics has applications in a wide variety of disorders including infectious diseases, cancer and cardiovascular. Molecular diagnostic testing is often complex and usually carried out in a lab environment. The trend and challenge is to create testing products which provide fast and accurate results in a clinical setting.
This is a competitively hot area with Beckman Coulter, Becton Dickinson, Siemens, bioMérieux, Roche and Gen-Probe all involved.
Customers who bought this item also bought
The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand
Republic of Korea In Vitro Diagnostics Market Outlook to 2016
Spain In Vitro Diagnostics Market Outlook to 2016
Canada In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
Germany In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
Sweden In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
Taiwan In Vitro Diagnostics Market Outlook to 2016
In-vitro and Companion Diagnostics Industry - 2010 Yearbook
Brazil In Vitro Diagnostics Market Outlook to 2016
Mexico In Vitro Diagnostics Market Outlook to 2016
|
 |
|
|